Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 31 December 2025

Broadcom stock slips today as insider sale filings hit tape in thin year-end trade

Broadcom stock slips today as insider sale filings hit tape in thin year-end trade

NEW YORK, December 31, 2025, 12:12 ET — Regular session Broadcom Inc. shares slipped in midday trading on Wednesday, down 0.7% at $347.36. The stock touched a session low of $345.43 as the final U.S. trading session of 2025 stayed choppy. The pullback matters because the semiconductor group is heading into 2026 with investors split on how much AI-driven spending can keep offsetting margin pressure from custom chips. Broadcom is a bellwether for that trade because it sells both AI-related silicon and enterprise software through VMware. Year-end trading can magnify small moves, and insider transactions draw extra attention in thin
31 December 2025
···
Regencell Bioscience (RGC) stock slides nearly 5% in year-end trading as volatility persists

Regencell Bioscience (RGC) stock slides nearly 5% in year-end trading as volatility persists

NEW YORK, December 31, 2025, 11:51 ET — Regular session Regencell Bioscience Holdings Limited shares were down 4.8% at $21.79 as of 11:51 a.m. ET, after trading between $21.44 and $23.11 in a choppy session. The move came without any new company announcements. Regencell’s investor-relations site lists its most recent press release dated Oct. 31, and the latest SEC filing on EDGAR is its annual report filed the same day. Regencell Bioscience -+1 The pullback also tracked a softer tape across Wall Street on the final trading day of 2025, with trading volumes muted heading into the New Year’s holiday.
31 December 2025
····
Genmab stock slides today as GMAB shelves acasunlimab; Merus takeout steps in focus

Genmab stock slides today as GMAB shelves acasunlimab; Merus takeout steps in focus

NEW YORK, December 31, 2025, 11:38 ET — Regular session Genmab A/S (GMAB) shares slid on Wednesday, down about 3.3% at $30.44 in New York trading, as investors weighed a late-stage pipeline cut and the closing steps of a major acquisition. The Nasdaq-listed ADR touched $30.36 after opening at $31.42. Genmab said on Dec. 29 it will discontinue further clinical development of acasunlimab following a portfolio review and said the move does not change its full-year 2025 financial guidance. “Although the data have been encouraging, the compelling opportunities we see in our late‑stage pipeline led us to focus our investments,”
31 December 2025
·····
Tesla stock today slips as TSLA braces for Q4 deliveries after Tesla posts analyst consensus

Tesla stock today slips as TSLA braces for Q4 deliveries after Tesla posts analyst consensus

NEW YORK, December 31, 2025, 11:55 ET — Regular session Tesla shares were down about 0.2% at $453.58 in late morning trading on Wednesday, extending a muted move as investors focused on near-term demand signals into year-end. The stock traded between $452.42 and $458.39 in the session. The market’s attention is on Tesla’s fourth-quarter and full-year production and delivery report due Friday, a closely watched update that investors use as an early read on demand before earnings. Analysts polled by Visible Alpha expect Tesla deliveries of about 432,810 vehicles for the quarter, down roughly 13% from a year earlier after
31 December 2025
·····
AMD stock today: Shares edge higher as traders eye Lisa Su’s CES keynote

AMD stock today: Shares edge higher as traders eye Lisa Su’s CES keynote

NEW YORK, December 31, 2025, 11:58 ET — Regular session Shares of Advanced Micro Devices rose about 0.3% to $215.92 in late-morning trading on Wednesday. The stock has ranged from $213.61 to $217.54 so far in the session. The move comes with investors squaring year-end positions and looking ahead to near-term catalysts in early January, including AMD’s scheduled appearance at the CES tech show in Las Vegas. AMD AMD heads into the close of 2025 after a sharp run that has shifted attention toward what comes next in the AI chip race. MarketWatch reported the stock has gained about 78%
31 December 2025
·····
Nvidia stock ticks higher after China H200 supply report; NVDA eyes CES, earnings

Nvidia stock ticks higher after China H200 supply report; NVDA eyes CES, earnings

NEW YORK, December 31, 2025, 11:52 ET — Regular session. Nvidia shares edged higher on Wednesday after a report said the company has approached Taiwan Semiconductor Manufacturing Co to ramp production of its H200 chips for Chinese customers. The stock was up 0.7% at $188.82 in late-morning New York trading. Reuters The development matters because Nvidia’s data-center products sit at the center of the AI spending boom, and any change in China access can swing expectations for demand and supply. The H200 is a graphics processing unit, or GPU — a specialized chip used to train and run AI models.
31 December 2025
····
Meta stock today: META slips after Reuters scam-ad “playbook” report as Manus AI deal stays in focus

Meta stock today: META slips after Reuters scam-ad “playbook” report as Manus AI deal stays in focus

NEW YORK, December 31, 2025, 11:57 ET — Regular session Meta Platforms shares dipped on Wednesday after a Reuters investigation said internal documents showed the Facebook and Instagram owner developed a “global playbook” to fend off pressure to crack down on scammers and delay tougher checks on advertisers. Meta was down 0.4% at $663 by 11:57 a.m. ET, after closing at $665.95 on Tuesday. The documents said Meta estimated universal advertiser verification — an identity check before ads run — could cost about $2 billion to implement and reduce revenue by up to 4.8%, while Google has said it has
31 December 2025
·····
Microsoft stock slips in late-morning trade as year-end tech selling weighs on megacaps

Microsoft stock slips in late-morning trade as year-end tech selling weighs on megacaps

NEW YORK, December 31, 2025, 11:52 ET — Regular session Microsoft (MSFT) shares fell 0.5% to $484.89 in late morning trading on Wednesday, after opening at $487.55. The stock has traded between $484.35 and $488.30, valuing the software maker at about $3.85 trillion. The dip matters now because Microsoft is one of the heaviest weights in the S&P 500 and Nasdaq, and year-end positioning can sway index performance. Wall Street’s major indexes slipped in holiday-thin trading, extending a late-December tech wobble that has tested the usual “Santa Claus rally” — a seasonal pattern that often sees stocks rise in the
31 December 2025
·····
Micron stock slips today as China’s CXMT targets $4.2 billion DRAM IPO

Micron stock slips today as China’s CXMT targets $4.2 billion DRAM IPO

NEW YORK, December 31, 2025, 12:00 ET — Regular session Micron Technology, Inc. shares were down about 1.8% at $287.35 in late-morning New York trading on Wednesday. The stock has ranged from $284.45 to $293.91 so far in the session, with about 9.2 million shares traded. The move matters now because Micron has become a high-sensitivity bet on memory pricing, where profits can swing quickly when supply or demand shifts. After a sharp run this year, investors have shown less tolerance for headlines that hint at fresh capacity. Micron has been among the strongest S&P 500 performers in 2025, with
31 December 2025
····
Nasdaq Keeps PLTS Trading Halted With No Reason Listed as Bengaluru ‘My Room, My Rules’ Row Spreads Online

Nasdaq Keeps PLTS Trading Halted With No Reason Listed as Bengaluru ‘My Room, My Rules’ Row Spreads Online

NEW YORK, December 31, 2025, 11:28 ET Nasdaq kept trading in Platinum Analytics Cayman Limited (PLTS) halted on Wednesday, with the reason listed as “not available” as of 10:23 a.m. ET, according to a Reuters market notice. TradingView The halt matters because it prevents investors from buying or selling the shares while they wait for clarity, a bigger issue in thin year-end trading when price swings can be sharper once a stock reopens. Nasdaq normally assigns a code when it pauses trading — including “news pending,” used when material news is expected, and “additional information requested,” which can follow a
31 December 2025
··
Why Life360 stock is sliding today as year-end trading hits tech names

Why Life360 stock is sliding today as year-end trading hits tech names

NEW YORK, December 31, 2025, 11:12 ET — Regular session Life360, Inc. shares were down 4.4% at $63.79 in morning trading, after moving between $63.79 and $67.05. The Nasdaq-listed stock was off $2.94 from Tuesday’s close and had traded about 108,000 shares. The move comes as investors close the books on the final trading day of 2025, a stretch that often brings thinner liquidity and sharper price swings in smaller growth stocks. Wall Street’s major indexes were slightly lower and tech stocks extended losses as markets looked ahead to the path of U.S. interest rates into 2026. “The economy showed
31 December 2025
······
PSLV stock today: Sprott Physical Silver Trust slides as silver retreats — what investors are watching

PSLV stock today: Sprott Physical Silver Trust slides as silver retreats — what investors are watching

NEW YORK, December 31, 2025, 11:08 ET — Regular session Sprott Physical Silver Trust (PSLV) slid 4.3% to $24.14 in Wednesday trading, tracking a renewed drop in silver prices after a record-setting run. The move matters because PSLV is one of the most heavily traded, exchange-listed ways to get exposure to physical silver, making it a quick read on sentiment when the metal turns volatile. Spot silver was down about 5% near $73 an ounce after hitting a record $83.62 on Monday, and it is up more than 150% year-to-date, Reuters reported. “The short-term is very choppy … but we
31 December 2025
·····
1 … 894 895 896 897 898 … 1,918

Stock Market Today

LSEG share price: London Stock Exchange Group stock braces for Monday after AI jitters and buyback move

LSEG share price: London Stock Exchange Group stock braces for Monday after AI jitters and buyback move

7 February 2026
London, Feb 7, 2026, 08:20 GMT — Market closed. London Stock Exchange Group plc (LSEG.L) shares ended Friday at 7,502 pence, down about 1.1% on the day, with London markets shut for the weekend and set to reopen on Monday. (MarketWatch) The stock has been caught in a wider repricing of software, data and analytics names as investors question which business models benefit from the next wave of AI — and which get squeezed. “It’s a de-risking trade,” Andrew Wells, chief investment officer at SanJac Alpha, said, as he argued the AI build-out had become “too pricey.” (Reuters) LSEG also
GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
Go toTop